[ 1 ]Structures of Gi-bound metabotropic glutamate receptors mGlu2 and mGlu4

[ 2 ]Mechanism of activation and biased signaling in complement receptor C5aR1

[ 3 ]Molecular insights into ligand recognition and activation of chemokine receptors CCR2 and CCR3

[ 4 ]Structural insights into ligand recognition and activation of the melanocortin-4 receptor

[ 5 ]Structural mechanism of calcium-mediated hormone recognition and Gβ interaction by the human melanocortin-1 receptor

[ 6 ]Structural basis for positive allosteric regulation of CB2 receptor

[ 7 ]Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors

[ 8 ]Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation

[ 9 ]Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1

[ 10 ]Ligand recognition and G-protein coupling selectivity of cholecystokinin A receptor

[ 11 ]Structural basis for activation of the growth hormone-releasing hormone receptor

[ 12 ]Modulating effects of RAMPs on signaling profiles of the glucagon receptor family

[ 13 ]Constitutive signal bias mediated by the human GHRHR splice variant 1

[ 14 ]Structural basis for dual targeting of μ-opioid and nociceptin/orphanin FQ receptors by Cebranopadol

[ 15 ]GRP75-driven, cell-cycle-dependent macropinocytosis of Tat/pDNA-Ca2+ nanoparticles underlies distinct gene therapy effect in ovarian cancer

[ 16 ]Structural insights into hormone recognition by the human glucose-dependent insulinotropic polypeptide receptor

[ 17 ]Structure–Activity Studies of a Novel Opioid Cyclic Hexapeptide Modified at Gly3: Identification of Highly Potent Agonists or Antagonists of Opioid Receptors

[ 18 ]Discovery of a dual FPR1/FPR2 antagonist via label-free screening with activity against lung injury

[ 19 ]Signaling profiles in HEK 293T cells co-expressing GLP-1 and GIP receptors

[ 20 ]Allosteric Modulators Enhancing GLP-1 Binding to GLP-1R via a Transmembrane Site

[ 21 ]High-throughput screening campaign identifies a small molecule agonist of the relaxin family peptide receptor 4

[ 22 ]Evaluation of biased agonism mediated by dual agonists of the GLP-1 and glucagon receptors

[ 23 ]Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors

[ 24 ]Constructing TC-1-GLUC-LMP2 Model Tumor Cells to Evaluate the Anti-Tumor Effects of LMP2-Related Vaccines